Clopidogrel reduces platelet-leucocyte aggregation, monocyte activation and RANTES secretion in type 2 diabetes mellitus. (Record no. 16496010)

MARC details
000 -LEADER
fixed length control field 01369 a2200373 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250515035529.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 200609s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1468-201X
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1136/hrt.2005.083006
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Harding, S A
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20060912
245 00 - TITLE STATEMENT
Title Clopidogrel reduces platelet-leucocyte aggregation, monocyte activation and RANTES secretion in type 2 diabetes mellitus.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Heart (British Cardiac Society)
Date of publication, distribution, etc. Sep 2006
300 ## - PHYSICAL DESCRIPTION
Extent 1335-7 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Letter; Research Support, Non-U.S. Gov't
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Chemokine CCL5
General subdivision metabolism
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Clopidogrel
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Diabetes Mellitus, Type 2
General subdivision blood
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Leukocytes, Mononuclear
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Lymphocyte Activation
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Middle Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Platelet Aggregation
General subdivision drug effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Platelet Aggregation Inhibitors
General subdivision pharmacology
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Ticlopidine
General subdivision analogs & derivatives
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Sarma, J
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Din, J N
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Maciocia, P M
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Newby, D E
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Fox, K A A
773 0# - HOST ITEM ENTRY
Title Heart (British Cardiac Society)
Related parts vol. 92
-- no. 9
-- p. 1335-7
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1136/hrt.2005.083006">https://doi.org/10.1136/hrt.2005.083006</a>
Public note Available from publisher's website

No items available.